Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery

NCT00731237 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT00731237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00731237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
October 31, 2008
Completion date
October 31, 2009
Enrollment
2,517 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, coronary artery disease